
    
      Study duration per participant is approximately 28 days for participants 6 months to < 9
      years of age, and 21 days for participants â‰¥ 65 years of age, including 1 to 3 visits (1 or 2
      vaccination visits) and 1 or 2 telephone calls, depending on study Group.

      The aim of study GRC00101 is to obtain serum samples for submission to CBER to aid in the
      influenza vaccine strain selection process.There are no endpoints defined in the protocol;
      however, the number of collected samples is listed as outcome for disclosure purposes since
      outcomes are mandatory for study registration.
    
  